SJ Medical
SJ Medical
The global angiographic catheter market is witnessing unprecedented growth, driven by the rising prevalence of cardiovascular diseases (CVDs) and a shift toward minimally invasive surgeries. Currently, North America and Europe dominate the market, but the Asia-Pacific region is emerging as the fastest-growing hub. Hospitals worldwide are increasingly adopting diagnostic and interventional radiology to ensure precise treatment planning.
Modern trends indicate a move toward Micro-catheters and Smart Catheters integrated with sensor technology. There is also a significant transition from femoral to radial access procedures to reduce patient recovery time and complications. Hydrophilic coatings and tip flexibility have become standard requirements for navigating complex vascular anatomies.
Professional buyers and medical institutions look for more than just a product; they seek a synergy of material science, regulatory compliance, and localized logistical support.
International distributors prioritize CE, ISO 13485, and CFDA certifications. High-quality angiographic catheters must demonstrate excellent torque control, radiopacity for visibility under X-ray, and biocompatibility. Cost-effectiveness is a major driver, leading many global buyers to partner with top-tier Chinese factories that offer premium quality at competitive pricing.
From Diagnostic Coronary Angiography in high-end cardiology labs to Peripheral Vascular Interventions in community clinics, these catheters are the "highway" for interventional tools. In neurovascular procedures, the demand for precision-engineered micro-catheters is surging, specifically for treating intracranial thrombosis and aneurysms.
Hangzhou SJ Medical Co., Ltd. was established in 2015 and is dedicated to the research, development, manufacturing, and commercialization of vascular interventional medical devices. The company focuses on both cardiovascular and peripheral intervention fields, striving to provide safe, reliable, and innovative solutions for healthcare providers worldwide.
Over the years, SJ Medical has developed a comprehensive product portfolio covering key areas of vascular intervention. Its offerings span from various types of balloon catheters for coronary and peripheral applications to supporting access and diagnostic devices, as well as advanced stent systems.
SJ Medical operates a modern manufacturing facility with a total area of approximately 5,000 square meters. The factory is built in accordance with GMP standards and features a high-standard cleanroom environment, including a million-class clean workshop with localized hundred-class areas for critical processes.
The company is supported by a highly experienced technical team. Under the leadership of senior engineers, SJ Medical maintains strict quality control and continuously improves its manufacturing processes to ensure product reliability and consistency. Our factory is equipped with laser welding, precision balloon forming, and comprehensive laboratory testing facilities.
SJ Medical strictly adheres to international quality standards. The company has obtained CE certification, ISO 13485, and CFDA approval, along with free sale certificates, demonstrating our strong commitment to global compliance.
Located in Hangzhou, a major tech and logistics hub in China, we ensure rapid lead times and efficient global shipping. Our production capacity allows us to fulfill large-scale OEM/ODM orders without compromising on precision.
From pre-sales consultation to responsive after-sales service, we provide comprehensive technical support. We assist our partners in navigating local registration requirements and clinical application challenges.
SJ Medical has established long-term partnerships with clients across Europe, Asia, the Middle East, and Africa. Our products are trusted in:
